Podcast

Diagnosis and Treatment of Pediatric Narcolepsy with Cataplexy

Launch Date
08/28/2020
Credit Amount
0.00 Expired
Credit Expires
08/28/2021

Faculty

Richard K. Bogan, MD, FCCP, FAASM
Associate Clinical Professor
University of South Carolina Medical School
Columbia, SC
Medical University of South Carolina
Charleston, SC
Principal, Bogan Sleep Consultants, LLC
Columbia, SC
Richard K. Bogan, MD, FCCP, FAASM

Dr. Bogan is the President of Bogan Sleep Consultants, LLC. He is also Associate Clinical Professor at the University of South Carolina School of Medicine and Associate Clinical Professor at the Medical University of South Carolina in Charleston, SC.

Dr. Bogan received his bachelor’s degree in chemistry from Wofford College and his MD degree from the Medical University of South Carolina in Charleston. He served his internship and residency, as well as Chief Medical Resident, at the University of Alabama Hospital and Clinics in Birmingham. Thereafter, he completed a fellowship and assistant professorship in the Pulmonary Division of the Department of Medicine at the University of Alabama School of Medicine. He has been certified by the American boards of Sleep Medicine, Internal Medicine, and Pulmonary Diseases.

Dr. Bogan has served as principal investigator on numerous clinical trials in the past and continues to do so now. He has a variety of publications and research interests that focus on topics such as narcolepsy, insomnia, sleep apnea, shift work sleep disorder, restless legs syndrome/periodic limb movement disorder, chronic fatigue/fibromyalgia, and circadian rhythm abnormality.

Michael J. Strunc, MD
Division Director of Child Neurology and Sleep, Children’s Hospital of The King’s Daughters
President, Virginia Academy of Sleep Medicine
Assistant Professor of Pediatrics Eastern Virginia Medical School
Assistant Professor of Pediatrics Uniformed Services University of Health Sciences Norfolk, VA
Michael J. Strunc, MD
Division Director of Child Neurology and Sleep, Children’s Hospital of The King’s Daughters

Dr. Michael J. Strunc is a pediatric neurologist and sleep medicine specialist practicing in southeastern Virginia. He is division director of child neurology and sleep at Children’s Hospital of the King’s Daughters in Norfolk, Virginia. He also serves as president of the Virginia Academy of Sleep Medicine, an organization that strives to educate and advocate for sleep needs in the state.

Dr. Strunc completed his pediatric training at Naval Medical Center San Diego, and following years of pediatric practice, trained in child neurology at University of Colorado and The Children’s Hospital, Denver CO. He completed his sleep training at Duke University.

Dr. Strunc retired after 20 years of active duty with the US Navy, and now resides in Chesapeake, Virginia. He is passionate about sleep, and having raised three children with his wife, is well aware of the daily struggles that families face regarding sleep issues and the consequences poor sleep can have.

Explore By Section
Statement of Need Learning Objectives Financial Support Target Audience Credit Information Disclosure Declaration Obtaining Credits

Statement of Need

Diagnosing and managing pediatric narcolepsy with cataplexy poses a significant challenge to clinicians. In younger children, EDS may be vague and present as behavioral problems or concentration difficulties, and its treatment is considered to be similar to that of adults. Yet, the same challenges in diagnosing and treating narcolepsy in adults seem to be exacerbated in children.

Validated tools such as EDS-CHAD can improve the detection of EDS in pediatric narcolepsy, and it is imperative for clinicians to focus on the presentation of EDS in pediatrics by discussing with their patients that being tired or fatigued is not the same as being sleepy, and checking for memory lapses, automatic behaviors, and impaired attention or concentration.

This CMEOCast podcast features the latest long-term safety and efficacy data for pediatric narcolepsy treatments, which can be utilized to develop the best possible treatment strategies for their patients.

Learning Objectives

At the end of this CME/CE activity, participants should be able to integrate long-term safety and efficacy data into treatment planning for pediatric narcolepsy with cataplexy.

The following learning objectives pertain only to those requesting CNE or CPE credit: Describe long-term safety and efficacy data for treatment planning for pediatric narcolepsy with cataplexy

Financial Support

Supported by an educational grant from Jazz Pharmaceuticals, Inc.

Target Audience

Sleep specialists, pulmonologists, neurologists, psychiatrists, primary care physicians, pediatricians, PAs, nurse practitioners, and pharmacists.

Credit Information

Physicians (ACCME) 1.0

CME Outfitters, LLC, designates this enduring material for a maximum of 1.0 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Pharmacists/Pharmacy Tech (ACPE) 1.0

This application-based activity is approved for 1.0 contact hour (0.10 CEUs) of continuing pharmacy credit.

ABIM MOC 1.0

Successful completion of this CME activity, which includes participation in the evaluation component, enables the participant to earn up to 1.0 medical knowledge MOC point in the American Board of Internal Medicine's (ABIM) Maintenance of Certification (MOC) program. Participants will earn MOC points equivalent to the amount of CME credits claimed for the activity. It is the CME activity provider's responsibility to submit participant completion information to ACCME for the purpose of granting ABIM MOC credit.

ABPN MOC

ABPN Diplomates may select any CME activity relevant to their practice to count towards ABPN MOC requirements.

Royal College MOC

Through an agreement between the Accreditation Council for Continuing Medical Education and the Royal College of Physicians and Surgeons of Canada, medical practitioners participating in the Royal College MOC Program may record completion of accredited activities registered under the ACCME’s “CME in Support of MOC” program in Section 3 of the Royal College’s MOC Program.

MIPS Improvement Activity

Completion of this accredited CME activity meets the expectations of an Accredited Safety or Quality Improvement Program (IA_PSPA_28) for the Merit-based Incentive Payment Program (MIPS). Clinicians should submit their improvement activities by attestation via the CMS Quality Payment Program website.

Note to Nurse Practitioners

Nurse Practitioners can apply for AMA PRA Category 1 Credit ™ through the American Academy of Nurse Practitioners (AANP). AANP will accept AMA PRA Category 1 Credit ™ from organizations accredited by the Accreditation Council for Continuing Medical Education. Nurse practitioners can also apply for credit through their state boards.

Note to PAs

AAPA accepts certificates of participation for educational activities certified for AMA PRA Category 1 Credit ™ from organizations accredited by the Accreditation Council for Continuing Medical Education.

Disclosure Declaration

It is the policy of CME Outfitters, LLC, to ensure independence, balance, objectivity, and scientific rigor and integrity in all of their CE activities. Faculty must disclose to the participants any relationships with commercial companies whose products or devices may be mentioned in faculty presentations, or with the commercial supporter of this CE activity. CME Outfitters, LLC, has evaluated, identified, and attempted to resolve any potential conflicts of interest through a rigorous content validation procedure, use of evidence-based data/research, and a multidisciplinary peer review process. The following information is for participant information only. It is not assumed that these relationships will have a negative impact on the presentations.

Dr. Bogan reports that he is a consultant for Harmony Biosciences, LLC; and Jazz Pharmaceuticals, Inc. He has done industry funded research for Avadel/Flamel Ireland LTD; Axsome Therapeutics, Inc.; Balance; Eisai Inc.; Fresca; Jazz Pharmaceuticals, Inc.; and Merck & Co., Inc. He is on the speakers bureau for Jazz Pharmaceuticals, Inc.; and Merck & Co., Inc. He is a shareholder, Board of Directors, Chief Medical Officer, and employee of SleepMed, Inc. He receives other financial or material support as a member of the Board of Directors, First Community Corporation, SC; and National Sleep Foundation.

Dr. Strunc reports that he receives research support from Jazz Pharmaceuticals, Inc. He is a consultant for Jazz Pharmaceuticals, Inc.

Tony Graham, MD (peer reviewer) has no disclosures to report.

Mae Ochoa, RPh (peer reviewer) has no disclosures to report.

Kashemi Rorie, PhD (planning committee) has no disclosures to report.

Evan Luberger (planning committee) has no disclosures to report.

Jan Perez (planning committee) has no disclosures to report.

Sharon Tordoff (planning committee) has no disclosures to report.

Disclosures were obtained from the CME Outfitters, LLC staff: No disclosures to report.

Faculty of this CE activity may include discussions of products or devices that are not currently labeled for use by the FDA. The faculty have been informed of their responsibility to disclose to the audience if they will be discussing off-label or investigational uses (any uses not approved by the FDA) of products or devices.

Obtaining Credits

Post-tests, credit request forms, and activity evaluations must be completed online (requires free account activation), and participants can print their certificate or statement of credit immediately (75% pass rate required). This website supports all browsers except Internet Explorer for Mac. For complete technical requirements and privacy policy, visit our Privacy & Confidentiality page.

 

NOTE: Pharmacist CE Universal Activity Number, Enduring: 0376-0000-20-120-H01-P.

Questions about this activity?

Call us at 877.CME.PROS (877.263.7767).

 

PD-034-082820-43

Diagnosis and Treatment of Pediatric Narcolepsy with Cataplexy
Event Date: 08/28/2020